Literature DB >> 8496602

Genomic structure and chromosomal mapping of the human CD22 gene.

G L Wilson1, V Najfeld, E Kozlow, J Menniger, D Ward, J H Kehrl.   

Abstract

The human CD22 gene is expressed specifically in B lymphocytes and likely has an important function in cell-cell interactions. A nearly full length human CD22 cDNA clone was used to isolate genomic clones that span the CD22 gene. The CD22 gene is spread over 22 kb of DNA and is composed of 15 exons. The first exon contains the major transcriptional start sites. The translation initiation codon is located in exon 3, which also encodes a portion of the signal peptide. Exons 4 to 10 encode the seven Ig domains of CD22, exon 11 encodes the transmembrane domain, exons 12 to 15 encode the intracytoplasmic domain of CD22, and exon 15 also contains the 3' untranslated region. A minor form of CD22 mRNA likely results from splicing of exon 5 to exon 8, skipping exons 6 and 7. A 4.6-kb XbaI fragment of the CD22 gene was used to map the chromosomal location of CD22 by fluorescence in situ hybridization. The hybridization locus was identified by combining fluorescent images of the probe with the chromosomal banding pattern generated by an Alu probe. The results demonstrate that CD22 is located within the band region q13.1 of chromosome 19. Two closely clustered major transcription start sites and several minor start sites were mapped by primer extension. Similarly to many other lymphoid-specific genes, the CD22 promoter lacks an obvious TATA box. Approximately 4 kb of DNA 5' of the transcription start sites were sequenced and found to contain multiple Alu elements. Potential binding sites for the transcriptional factors NF-kappa B, AP-1, and Oct-2 are located within 300 bp 5' of the major transcription start sites. A 400-bp fragment (bp -339 through +71) of the CD22 promoter region was subcloned into a pGEM-chloramphenicol acetyltransferase vector and after transfection into B and T cells was found to be active in both B and T cells. Further studies of the CD22 gene should lead to a greater understanding of the expression of CD22 during B cell development and differentiation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496602

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia.

Authors:  Fatih M Uckun; Patricia Goodman; Hong Ma; Ilker Dibirdik; Sanjive Qazi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-14       Impact factor: 11.205

Review 2.  The Sialoadhesins--a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily.

Authors:  S Kelm; R Schauer; P R Crocker
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

3.  Differential expression of CD22 (Lyb8) on murine B cells.

Authors:  L D Erickson; L T Tygrett; S K Bhatia; K H Grabstein; T J Waldschmidt
Journal:  Int Immunol       Date:  1996-07       Impact factor: 4.823

4.  Multiple motifs regulate the B-cell-specific promoter of the B29 gene.

Authors:  S A Omori; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

5.  Chromosomal localization, genomic structure, and allelic polymorphism of the human CD79 alpha (Ig-alpha/mb-1) gene.

Authors:  S Hashimoto; H W Mohrenweiser; P K Gregersen; N Chiorazzi
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Induction of transcription within chromosomal DNA loops flanked by MAR elements causes an association of loop DNA with the nuclear matrix.

Authors:  Olga V Iarovaia; Sergey B Akopov; Lev G Nikolaev; Eugene D Sverdlov; Sergey V Razin
Journal:  Nucleic Acids Res       Date:  2005-07-26       Impact factor: 16.971

7.  Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.

Authors:  P Engel; N Wagner; A S Miller; T F Tedder
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

8.  Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells.

Authors:  M Falco; R Biassoni; C Bottino; M Vitale; S Sivori; R Augugliaro; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

9.  Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulation.

Authors:  Kazumi Hayashi; Eijiro Nagasaki; Shin Kan; Masaki Ito; Yuko Kamata; Sadamu Homma; Keisuke Aiba
Journal:  Cancer Sci       Date:  2016-04-07       Impact factor: 6.716

10.  Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains.

Authors:  P R Crocker; S Mucklow; V Bouckson; A McWilliam; A C Willis; S Gordon; G Milon; S Kelm; P Bradfield
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.